Advanced Care Management in Patients With Advanced Heart Failure

NCT ID: NCT03526627

Last Updated: 2020-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

227 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-04

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted by patients after 2 years later and compliance with the preferences of patients and their families.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

this study is to observe the trajectory of the advanced care management on patients with advanced heart failure and follow the difference between the actual medical treatment accepted by patients on 2years later and the preference of the patient and their families.

the advance care management in this study is mean the patients who know about the preference of medical treatment, communication, and prognosis of illness. we also measure the sense of coherence, self-efficacy and their quality of life to compare their relationship of the advanced care management.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Advanced Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient with advanced heart failure

we included the patients with advanced heart failure who had the poor cardiac function(LVEF\<=30%) and was admitted to the general ward or emergency room within one year.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed with AHA stage D, or NYHA class function 4, or LVEF\<=30%.
* has one or more than one symptoms such as dyspnea, lower legs edema, weakness.
* ever admission to the hospital (include emergency room or the general room)

Exclusion Criteria

* with other end-stage diseases such cancer, dementia, COPD, ESRD...etc.
* had other physical, cognitive, or psychological condition which may influence their answer.
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kai-di Kao

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, Zhongzheng, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kai-di Kao

Role: CONTACT

+886928846909

Shiu-yu Chiu, PhD

Role: CONTACT

886-2-2822-7101 ext. 3316

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kai-di Kao

Role: primary

886-928846909

Shiu-yu Chiu

Role: backup

886-2-2822-7101 ext. 3316

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201711101RIND

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhancing Heart Failure Self-Care
NCT00526773 COMPLETED NA
Prognostic Model Heart Failure
NCT06414928 RECRUITING